Literature DB >> 12469217

Analysis of the epidermal growth factor receptor promoter: the effect of nuclear factor-kappaB.

Hirotaka Nishi1, Gila Neta, Katsura H Nishi, Latania M Akers, Toshiki Rikiyama, Kimberle N Proctor, Barbara A Murphy, Alfred C Johnson.   

Abstract

The epidermal growth factor receptor gene is highly regulated and responsive to extracellular stimuli that control cell growth. We have identified five putative nuclear factor-kappaB (NF-kappaB) binding sites within the epidermal growth factor receptor (EGFR) promoter region by sequence analysis. We have analyzed the potential role of NF-kappaB family members in the regulation of the EGFR transcription. Electrophoretic mobility shift analysis demonstrated that the p50 and p49, subunit proteins of the NF-kappaB, bound to the EGFR promoter at four out of five of these sites. However, it was found that NF-kappaB could not transactivate the EGFR by cotransfection experiments with each NF-kappaB subunit, using p50, p65 and c-Rel and an EGFR promoter luciferase reporter. Treatment of cells with tumor necrosis factor (TNF)-alpha, which could degrade the I-kappaB and then result in translocation of NF-kappaB to nucleus, did not enhance EGFR promoter reporter gene transcription. Also, TNF-alpha did not induce EGFR expression at the protein level. These results indicate that even though purified NF-kappaB can bind to the putative sites, there is no evidence that NF-kappaB transactivates the EGFR promoter region.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12469217

Source DB:  PubMed          Journal:  Int J Mol Med        ISSN: 1107-3756            Impact factor:   4.101


  7 in total

Review 1.  Mechanisms of resistance to anti-EGFR monoclonal antibody treatment in metastatic colorectal cancer.

Authors:  Zacharenia Saridaki; Vassilis Georgoulias; John Souglakos
Journal:  World J Gastroenterol       Date:  2010-03-14       Impact factor: 5.742

2.  Breast cancer metastasis suppressor-1 differentially modulates growth factor signaling.

Authors:  Kedar S Vaidya; Sitaram Harihar; Pushkar A Phadke; Lewis J Stafford; Douglas R Hurst; David G Hicks; Graham Casey; Daryll B DeWald; Danny R Welch
Journal:  J Biol Chem       Date:  2008-07-29       Impact factor: 5.157

3.  Induction of epidermal growth factor receptor expression by Epstein-Barr virus latent membrane protein 1 C-terminal-activating region 1 is mediated by NF-kappaB p50 homodimer/Bcl-3 complexes.

Authors:  Natalie J Thornburg; Nancy Raab-Traub
Journal:  J Virol       Date:  2007-09-19       Impact factor: 5.103

4.  Heparin-binding epidermal growth factor-like growth factor signaling in flow-induced arterial remodeling.

Authors:  Hua Zhang; Susan W Sunnarborg; K Kirk McNaughton; Terrance G Johns; David C Lee; James E Faber
Journal:  Circ Res       Date:  2008-04-24       Impact factor: 17.367

5.  2-Triazenoazaindoles: α novel class of triazenes inducing transcriptional down-regulation of EGFR and HER-2 in human pancreatic cancer cells.

Authors:  Jan N Kreutzer; Alessia Salvador; Patrizia Diana; Girolamo Cirrincione; Daniela Vedaldi; David W Litchfield; Olaf-Georg Issinger; Barbara Guerra
Journal:  Int J Oncol       Date:  2011-11-29       Impact factor: 5.650

6.  EGCG inhibits proliferation, invasiveness and tumor growth by up-regulation of adhesion molecules, suppression of gelatinases activity, and induction of apoptosis in nasopharyngeal carcinoma cells.

Authors:  Chih-Yeu Fang; Chung-Chun Wu; Hui-Yu Hsu; Hsin-Ying Chuang; Sheng-Yen Huang; Ching-Hwa Tsai; Yao Chang; George Sai-Wah Tsao; Chi-Long Chen; Jen-Yang Chen
Journal:  Int J Mol Sci       Date:  2015-01-23       Impact factor: 5.923

7.  Oncogenic K-Ras and loss of Smad4 mediate invasion by activating an EGFR/NF-κB Axis that induces expression of MMP9 and uPA in human pancreas progenitor cells.

Authors:  Alakesh Bera; Shujie Zhao; Lin Cao; Paul J Chiao; James W Freeman
Journal:  PLoS One       Date:  2013-12-05       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.